Pembrolizumab Plus Bevacizumab and Chemotherapy for Non-Squamous NSCLC Patients
Clinical trial NCT05751187 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05751187
- Sponsor
- Shanghai Chest Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-27
- Primary completion
- 2025-12-15
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.